Literature DB >> 17452828

Botulinum toxin in closed treatment of mandibular condylar fracture.

Halil Ibrahim Canter1, Aycan Kayikcioglu, Muge Aksu, Mehmet Emin Mavili.   

Abstract

BACKGROUND: The topic of condylar injury in adults has generated more discussion and controversy than any other in the field of maxillofacial trauma. The treatment of condylar fractures in adults is still a highly debated theme.
METHODS: Patients with unilateral subcondylar or condylar neck fractures of the mandibula without any significant angulation of the condylar head were managed with closed-treatment protocol. Closed treatment was applied through the injection of 100 units of botulinum toxin A, diluted to a concentration of 20 IU/mL, into the muscles of mastication of the fractured side. Masseter and anterior fibers of temporalis muscles were reached through percutaneous extraoral route and 30 IU of the toxin was injected to each muscle. Additional 40 IU of the toxin was injected around the fractured bone fragments through transmucosal intraoral route to paralyze medial and lateral pterygoid muscles as much as possible. An asymmetric occlusal splint was applied for maxillomandibular fixation to restore the vertical height for 10 days. Functional therapy with intermaxillary guiding elastics was advocated for 2 months.
RESULTS: There were no complications related to either toxin injections or splint application procedures. The toxin was effective on all occasions. Fractured condylar process and ramus of the mandibula were in good approximation and remained in reduced positions. None of the patients had any occlusal disturbance, mandibular asymmetry, or joint dysfunction in the follow-up period.
CONCLUSIONS: We believe that modification of treatment options concerning the clinical situation of the patients is the best method for condylar injury. The purpose of this study is to present and discuss the results achieved in closed treatment of a selected group of patients with mandibular condylar fractures to whom botulinum toxin A was injected to relieve the spasm of muscles of mastication, along with special splint application.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17452828     DOI: 10.1097/01.sap.0000244987.68092.6e

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  6 in total

1.  Bone and cartilage changes in rabbit mandibular condyles after 1 injection of botulinum toxin.

Authors:  Tori Matthys; Hong An Ho Dang; Katherine L Rafferty; Susan W Herring
Journal:  Am J Orthod Dentofacial Orthop       Date:  2015-12       Impact factor: 2.650

2.  Botulinum toxin in masticatory muscles: short- and long-term effects on muscle, bone, and craniofacial function in adult rabbits.

Authors:  Katherine L Rafferty; Zi Jun Liu; Wenmin Ye; Alfonso L Navarrete; Thao Tuong Nguyen; Atriya Salamati; Susan W Herring
Journal:  Bone       Date:  2011-12-02       Impact factor: 4.398

3.  Botulinum neurotoxin type A in the masseter muscle: effects on incisor eruption in rabbits.

Authors:  Alfonso L Navarrete; Katherine L Rafferty; Zi Jun Liu; Wenmin Ye; Geoffrey M Greenlee; Susan W Herring
Journal:  Am J Orthod Dentofacial Orthop       Date:  2013-04       Impact factor: 2.650

Review 4.  Applications of botulinum toxin in dentistry: A comprehensive review.

Authors:  Sanjeev Srivastava; Smriti Kharbanda; U S Pal; Vinit Shah
Journal:  Natl J Maxillofac Surg       Date:  2015 Jul-Dec

5.  Protrusive maxillomandibular fixation for intracapsular condylar fracture: a report of two cases.

Authors:  Yeong Kon Jeong; Won-Jong Park; Il Kyung Park; Gi Tae Kim; Eun Joo Choi
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2017-10-26

6.  Validity and Reliability of the Helkimo Clinical Dysfunction Index for the Diagnosis of Temporomandibular Disorders.

Authors:  Roger Alonso-Royo; Carmen María Sánchez-Torrelo; Alfonso Javier Ibáñez-Vera; Noelia Zagalaz-Anula; Yolanda Castellote-Caballero; Esteban Obrero-Gaitán; Daniel Rodríguez-Almagro; Rafael Lomas-Vega
Journal:  Diagnostics (Basel)       Date:  2021-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.